National Institute of Virology: Current Affairs, GK & News - 2020-2021

COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India

Published: November 17, 2020

On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to be held in partnership with the Indian Council of Medical Research. The trials are the largest clinical trials that is conducted for COVID-19 vaccine in the country. ..

Month: 

Category: 

Topics: 

Indigenously Developed ‘COVAXIN’ gets DCGI approval for Human Clinical Trials

Published: June 30, 2020

The Drug Controller General of India (DCGI) has given approval for Phase I and Phase II human clinical trials for COVID-19 vaccine ‘COVAXIN’. In association with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), COVAXIN is developed by Hyderabad based vaccine & bio-therapeutics manufacturer-Bharat Biotech.  At NIV Pune, the ..

Month: 

Category: 

Topics: 

Sero-Survey begins in New Delhi to determine the Spread of COVID-19

Published: June 27, 2020

As a part of one of the five aspects of the revised COVID-19 response plan of New Delhi, the Delhi Government jointly with National Centre for Disease Control will conduct the Sero Survey across the National Capital from 27th June 2020. Amidst a rising number of COVID-19 cases over the last one month, the Survey ..

Month: 

Topics: 

Advertisement